Recent Articles from Chartmill
ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Website: https://www.chartmill.com
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the top gainers and losers in the S&P500 index.
Via Chartmill · November 4, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · November 4, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.
Via Chartmill · November 4, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · November 4, 2025
Stay informed about the most active stocks in the S&P500 index on Tuesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · November 4, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.
Via Chartmill · November 4, 2025
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session.
Via Chartmill · November 4, 2025
Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via Chartmill · November 4, 2025
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · November 4, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · November 4, 2025
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.
Via Chartmill · November 4, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · November 4, 2025
Tango Therapeutics (TNGX) reported a strong Q3, beating revenue and EPS estimates. Despite the earnings beat, the stock saw mixed market reaction.
Via Chartmill · November 4, 2025
Premier Inc. (PINC) reported mixed Q1 FY2026 results, with revenue missing estimates but adjusted EPS beating forecasts. The company also withdrew guidance due to a pending acquisition.
Via Chartmill · November 4, 2025
Heron Therapeutics reported mixed Q3 2025 results, missing revenue and earnings estimates. Despite strong growth from its Acute Care products, the miss led to a negative market reaction.
Via Chartmill · November 4, 2025
Core Molding Tech (CMT) shares fell after missing Q3 2025 earnings and revenue estimates. The company also lowered its full-year sales guidance, citing a challenging market.
Via Chartmill · November 4, 2025
Great Lakes Dredge & Dock (GLDD) Q3 2025 earnings beat estimates by 50%, driving shares up. Strong profitability and a $934M backlog signal a positive outlook for 2026.
Via Chartmill · November 4, 2025
Expeditors International (EXPD) beat Q3 2025 earnings estimates with strong airfreight and customs results, despite challenges in the ocean freight market.
Via Chartmill · November 4, 2025
Delcath Systems reported Q3 2025 revenue below estimates but met earnings targets. The interventional oncology firm showed strong product growth and clinical progress.
Via Chartmill · November 4, 2025
Exagen's Q3 2025 results show a revenue beat but a wider-than-expected loss, causing a pre-market stock decline.
Via Chartmill · November 4, 2025
Portillo's Q3 2025 earnings miss estimates as profits fall sharply. Revenue guidance is below expectations, and same-store sales decline.
Via Chartmill · November 4, 2025
Oxford Square Capital (OXSQ) reported Q3 2025 results with revenue beating estimates. NAV per share rose to $2.92, and it declared steady distributions for early 2026.
Via Chartmill · November 4, 2025
AG Mortgage Investment Trust (MITT) reported mixed Q3 2025 results, beating earnings estimates but missing on revenue. The REIT also increased its stake in Arc Home.
Via Chartmill · November 4, 2025
Uniti Group's Q3 2025 results show an EPS beat and strong fiber growth, with a positive market reaction despite a revenue miss.
Via Chartmill · November 4, 2025
IPG Photonics (IPGP) beat Q3 2025 earnings and revenue estimates, with EPS soaring 155% above forecasts. Strong operational performance and positive guidance highlight solid execution.
Via Chartmill · November 4, 2025
Hamilton Lane (HLNE) Q2 FY2026 earnings beat analyst forecasts, with revenue of $190.88M and EPS of $1.54, driving a positive pre-market stock reaction.
Via Chartmill · November 4, 2025
TPG's Q3 2025 results show strong operational growth with record capital deployment, but revenue and earnings per share fell short of Wall Street estimates.
Via Chartmill · November 4, 2025
AdaptHealth (AHCO) Q3 2025 earnings beat revenue estimates but missed on EPS. The stock rose as investors focused on the revenue beat and strong operational progress.
Via Chartmill · November 4, 2025
Hagerty (HGTY) Q3 earnings crush estimates, with a 60% EPS beat. The company raises its full-year 2025 outlook, projecting strong revenue and profit growth.
Via Chartmill · November 4, 2025
Yum! Brands Q3 2025 earnings beat EPS estimates, but revenue slightly missed. The stock rose as the company announced a strategic review for Pizza Hut and strong Taco Bell growth.
Via Chartmill · November 4, 2025
Amicus Therapeutics (FOLD) beats Q3 2025 earnings estimates with strong revenue growth and a major milestone in profitability, driving positive market momentum.
Via Chartmill · November 4, 2025
Hillman Solutions posts record Q3 2025 results, beating earnings estimates but its conservative sales outlook tempers investor enthusiasm.
Via Chartmill · November 4, 2025
Chicago Atlantic (REFI) reported mixed Q3 2025 results, beating EPS estimates with $0.49 but missing revenue forecasts. The cannabis industry lender showed profit strength despite a top-line shortfall.
Via Chartmill · November 4, 2025
Robinhood (HOOD) is a high-growth stock in a powerful technical uptrend, meeting strict criteria for explosive earnings and strong price momentum.
Via Chartmill · November 4, 2025
DAVE INC (DAVE) smashed Q3 2025 earnings forecasts, posting record revenue and a huge EPS beat. The strong results, driven by user growth, sent the stock soaring.
Via Chartmill · November 4, 2025
Zoetis (ZTS) Q3 2025 results show an EPS beat but a revenue miss and lowered full-year sales guidance, causing a sharp pre-market stock drop.
Via Chartmill · November 4, 2025
PJT Partners Q3 2025 earnings smash expectations with record $447.1M revenue, a 37% surge. Strong advisory and placement fees drove the beat.
Via Chartmill · November 4, 2025
SunCoke Energy (SXC) reported mixed Q3 2025 results, with earnings beating estimates despite a slight revenue dip. Its new industrial services segment surged, offsetting coke segment challenges.
Via Chartmill · November 4, 2025
LGI Homes Q3 2025 results show a slight revenue beat but a significant earnings miss. The homebuilder's stock fell as investor focus remained on declining profits and a cautious outlook.
Via Chartmill · November 4, 2025
Telesat (TSAT) Q3 2025 earnings crush estimates, sending shares up 7% in pre-market trading on strong profitability.
Via Chartmill · November 4, 2025
CDW's Q3 2025 results show steady revenue growth and an EPS beat of $2.71, but the stock dipped slightly on a minor revenue miss.
Via Chartmill · November 4, 2025
Martin Marietta (MLM) reported mixed Q3 2025 results, missing analyst EPS and revenue estimates despite highlighting record operational achievements.
Via Chartmill · November 4, 2025
Broadridge Q1 FY2026 earnings crush estimates with EPS of $1.51, a 51% jump. The firm also raises its full-year recurring revenue growth outlook.
Via Chartmill · November 4, 2025
Madrigal's Q3 2025 earnings show Rezdiffra sales of $287.3M, crushing estimates. With over 29,500 patients on therapy, the stock surged on strong commercial uptake.
Via Chartmill · November 4, 2025
Sotera Health (SHC) Q3 2025 earnings beat estimates, with revenue of $311.3M and EPS of $0.26. The company also raised its full-year profit guidance.
Via Chartmill · November 4, 2025
Reservoir Media (RSVR) posted a Q2 revenue beat but an earnings miss. The music company raised its full-year 2026 outlook, highlighting strong growth.
Via Chartmill · November 4, 2025
Lindblad Expeditions Q3 earnings beat expectations with strong revenue and EPS growth, driving a 7%+ stock surge on robust travel demand.
Via Chartmill · November 4, 2025
OCULAR THERAPEUTIX reported mixed Q3 2025 results, with a slight revenue miss but a narrower-than-expected loss. The company highlighted progress in its AXPAXLI clinical pipeline.
Via Chartmill · November 4, 2025
Genius Sports Q3 2025 revenue surged 38% to $166.3M, beating estimates. Despite an EPS miss, the company raised its full-year 2025 guidance.
Via Chartmill · November 4, 2025
Kodiak Gas Services (KGS) is a technical breakout candidate with strong momentum, trading above key moving averages and forming a consolidation pattern.
Via Chartmill · November 4, 2025
Orthofix (OFIX) Q3 2025 earnings beat estimates with $0.20 EPS vs. $(0.41) forecast. Revenue of $205.6M also surpassed expectations, driven by strong spine and orthopedics growth.
Via Chartmill · November 4, 2025
Costamare (CMRE) Q3 2025 earnings and revenue beat analyst estimates, driving a positive market reaction for the shipping company.
Via Chartmill · November 4, 2025
Verastem's Q3 2025 results show a strong revenue beat from its new cancer drug launch, while its net loss widened. The stock dipped slightly on the mixed earnings news.
Via Chartmill · November 4, 2025
Driven Brands (DRVN) beat Q3 2025 profit estimates with EPS of $0.34. Revenue of $535.7M slightly missed forecasts. The stock rose on strong earnings and improved leverage.
Via Chartmill · November 4, 2025
Harley-Davidson's Q3 2025 earnings beat estimates despite a revenue decline, highlighting a mixed financial picture for the motorcycle maker.
Via Chartmill · November 4, 2025
Silicon Labs (SLAB) Q3 2025 results show mixed performance with revenue slightly below estimates but a beat on EPS, driving a positive pre-market stock reaction.
Via Chartmill · November 4, 2025
Bioventus (BVS) reported strong Q3 2025 earnings, beating EPS estimates with a 200% surge. While revenue slightly missed, organic growth was up 8.2%.
Via Chartmill · November 4, 2025
Axcelis (ACLS) Q3 2025 earnings and revenue beat analyst estimates, sending shares higher in pre-market trading on strong profit margins.
Via Chartmill · November 4, 2025
Shoals (SHLS) Q3 2025 earnings beat revenue estimates and provided strong guidance, yet the stock fell due to a slight EPS miss.
Via Chartmill · November 4, 2025
CPI Card Group Q3 2025 earnings beat EPS estimates but revenue missed. Shares fell as the company lowered its full-year sales and profit outlook.
Via Chartmill · November 4, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Via Chartmill · November 4, 2025
Xometry (XMTR) Q3 2025 earnings beat estimates with record revenue and strong profit growth, sending shares up in pre-market trading.
Via Chartmill · November 4, 2025
Sphere Entertainment's Q3 earnings show mixed results with revenue growth but a wider-than-expected loss, causing a negative market reaction.
Via Chartmill · November 4, 2025
Sealed Air (SEE) beat Q3 2025 earnings estimates with strong EPS of $0.87, driving a positive market reaction.
Via Chartmill · November 4, 2025
Marriott (MAR) reported mixed Q3 2025 results, beating earnings estimates with $2.47 EPS but slightly missing on revenue at $6.49B.
Via Chartmill · November 4, 2025
Knife River (KNF) reported mixed Q3 2025 results, missing revenue estimates but achieving record EBITDA and margins, boosting its stock.
Via Chartmill · November 4, 2025
Harmony Biosciences Q3 2025 earnings beat estimates with strong WAKIX growth. Despite the beat, stock dipped slightly in pre-market trading.
Via Chartmill · November 4, 2025
Lantheus Holdings (LNTH) appears undervalued with strong fundamentals. Its low P/E ratio, robust profitability, and healthy balance sheet make it a compelling value investing candidate.
Via Chartmill · November 4, 2025
Marzetti Company (MZTI) reported record Q1 earnings and revenue, beating analyst estimates with strong performance in both Retail and Foodservice segments.
Via Chartmill · November 4, 2025
Kymera Therapeutics stock rises on positive clinical updates for its atopic dermatitis drug, KT-621, despite missing Q3 2025 revenue and EPS estimates.
Via Chartmill · November 4, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · November 4, 2025
Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss.
Via Chartmill · November 4, 2025
ADT Q3 2025 earnings: Revenue slightly missed estimates, but profit beat forecasts. The company also narrowed its full-year guidance and highlighted strong cash flow.
Via Chartmill · November 4, 2025
Anywhere Real Estate (HOUS) missed Q3 2025 revenue and EPS estimates, reporting $0.00 EPS versus a $0.23 forecast, signaling profitability challenges.
Via Chartmill · November 4, 2025
Vital Farms (VITL) Q3 2025 earnings beat estimates with revenue of $198.9M and EPS of $0.36. The stock surged over 8% as the company raised its full-year outlook.
Via Chartmill · November 4, 2025